Physician

Hakam Khazrik, MD

According to 2025 Medicare claims, Hakam Khazrik, MD (NPI: 1154617496) practices medical oncology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 32778-5270.

Khazrik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 711 traditional Medicare patients, billed 97,375 HCPCS/CPT codes, and received $1,647,795 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 532 prescription claims across 126 beneficiaries totaling $716,911 in drug costs, led by Revlimid (Lenalidomide). DME data shows 12 claims. Open Payments data shows 129 records totaling $2,806. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $120,724 to $1,647,795. Similarly, Part D prescription costs have moved sharply higher in recent years, from $19,731 to $716,911. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,178 to $224.